Charles Conway - Net Worth and Insider Trading

Charles Conway Net Worth

The estimated net worth of Charles Conway is at least $56,320 dollars as of 2024-05-13. Charles Conway is the Chief Scientific Officer of Biohaven Pharmaceutical Holding Co Ltd and owns about 4,000 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $56,320. Details can be seen in Charles Conway's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles Conway has not made any transactions after 2017-05-09 and currently still holds the listed stock(s).

Transaction Summary of Charles Conway

To

Charles Conway Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles Conway owns 1 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) .

Click here to see the complete history of Charles Conway’s form 4 insider trades.

Insider Ownership Summary of Charles Conway

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2017-05-09 Chief Scientific Officer

Charles Conway Latest Holdings Summary

Charles Conway currently owns a total of 1 stock. Charles Conway owns 4,000 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of May 9, 2017, with a value of $56,320.

Latest Holdings of Charles Conway

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Pharmaceutical Holding Co Ltd 2017-05-09 4,000 14.08 56,320

Holding Weightings of Charles Conway


Charles Conway Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles Conway has made a total of 0 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 4,000 shares on May 9, 2017, which cost Charles Conway around $68,000.

Insider Trading History of Charles Conway

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles Conway Trading Performance

GuruFocus tracks the stock performance after each of Charles Conway's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Conway is 21.81%. GuruFocus also compares Charles Conway's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Conway within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Charles Conway's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Charles Conway

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.31
Relative Return to S&P 500(%) 6.86

Charles Conway Ownership Network

Ownership Network List of Charles Conway

No Data

Ownership Network Relation of Charles Conway


Charles Conway Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

Charles Conway is the Chief Scientific Officer of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biohaven Pharmaceutical Holding Co Ltd Insider Transactions

No Available Data

Charles Conway Mailing Address

Above is the net worth, insider trading, and ownership report for Charles Conway. You might contact Charles Conway via mailing address: C/o Biohaven Pharmaceutical Holding Comp 234 Church Street New Haven Ct 06510.

Discussions on Charles Conway

No discussions yet.